Literature DB >> 10570088

Tuberculosis prophylaxis for the chronically dialysed patient--yes or no?

A Korzets1, U Gafter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10570088     DOI： 10.1093/ndt/14.12.2857

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

1.  Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Gumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

3.  High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.

Authors:  S S J Lee; K J Chou; I J Su; Y S Chen; H C Fang; T S Huang; H C Tsai; S R Wann; H H Lin; Y C Liu
Journal:  Infection       Date:  2008-12-10       Impact factor: 3.553

Review 4.  Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy - case report and literature review.

Authors:  Stefan Matei Constantinescu; Benoit Buysschaert; Vincent Haufroid; Franck Broly; Michel Jadoul; Johann Morelle
Journal:  BMC Nephrol       Date:  2017-09-04       Impact factor: 2.388

5.  Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial.

Authors:  Antonios I Christopoulos; Athanasios A Diamantopoulos; Panagiotis A Dimopoulos; Demetrios S Goumenos; George A Barbalias
Journal:  BMC Nephrol       Date:  2009-11-07       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.